Managing HIV. Part 4: Primary therapy. 4.2 Immune-based therapy for HIV infection.
Where this comes from
- Record sourced from PubMed, PMID 8628166.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Immune-based therapy is in its infancy and to date no therapies are licensed in Australia. A number of the reagents are reaching phase III clinical trials and may be available within two years. Patient and physician interest is high because antiretroviral agents have not as yet had a significant impact on survival.